Literature DB >> 16313271

Quality-adjusted life years: how useful in medico economic studies.

Carmen A Brauer1, Peter J Neumann.   

Abstract

Cost-effectiveness analysis has evolved as a practical response to the need to allocate limited resources for health care. It can be used to compare interventions whose effects on health are different if the measure of effectiveness captures all the important health dimensions of the effects of the interventions. Using the quality-adjusted life year (QALY) as the unit of effectiveness attempts to approach this ideal and is currently the approach recommended by many consensus groups. Conventional QALYs represent time spend in a series of "quality-weighted" health states, where the quality weights reflect the desirability of living in the state. Many challenges arise when preferences are incorporated into an economic analysis. The purpose of this paper is to highlight some of the issues surrounding the use of QALYs and to encourage researchers to present their methodology in a clear and transparent way.

Mesh:

Year:  2005        PMID: 16313271     DOI: 10.1111/j.1472-8206.2005.00369.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  2 in total

Review 1.  Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.

Authors:  Clare McGrath; Diana Rofail; Elizabeth Gargon; Linda Abetz
Journal:  Health Qual Life Outcomes       Date:  2010-02-12       Impact factor: 3.186

2.  [Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].

Authors:  G Gakis; B Volkmer; B Qvick; F Marteau; A Stenzl
Journal:  Urologe A       Date:  2019-01       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.